Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

February 18, 2025

Study Completion Date

February 18, 2025

Conditions
Prostate CancerProstate AdenocarcinomaBiochemical Recurrence of Malignant Neoplasm of Prostate
Interventions
DRUG

Copper Cu 64 PSMA I&T

Radiopharmaceutical PET imaging tracer injected intravenously for the detection of PSMA expression.

Trial Locations (31)

10468

James J. Peters VA Medical Center, The Bronx

11432

Queens Hospital Center, Jamaica

20007

Georgetown University Medical Center, Washington D.C.

29572

Carolina Urologic Research Center, LLC, Myrtle Beach

33136

University of Miami Miller School of Medicine, Miami

33165

Biogenix Molecular, LLC, Miami

33615

Florida Urology Partners, Tampa

37920

University of Tennessee Medical Center, Knoxville

44195

Cleveland Clinic, Cleveland

46032

Urology of Indiana, LLC, Carmel

46202

Indiana University Health Neuroscience Center, Indianapolis

52242

University of Iowa, Iowa City

55455

M Health Fairview University of Minnesota Medical Center, Minneapolis

60141

Edward Hines Jr VA Hospital, Hines

63104

SSM Health Saint Louis University Hospital, St Louis

63106

John Cochran VA Medical Center, St Louis

63110

Washington University School of Medicine, St Louis

66160

The University of Kansas Hospital, Kansas City

68130

XCancer, Omaha

69101

Great Plains Health, Diagnostic Imaging, North Platte

77042

Excel Diagnostics and Nuclear Oncology Center, Houston

78229

Urology San Antonio, San Antonio

90048

Tower Urology, Los Angeles

90073

VA Greater Los Angeles Healthcare System, Los Angeles

90404

Providence Saint John's Health Center, Santa Monica

92663

Hoag Memorial Hospital Presbyterian, Newport Beach

92835

Providence Medical Foundation, Fullerton

92868

University of California, Irvine, Orange

94121

San Francisco VA Medical Center, San Francisco

94305

Stanford Hospital & Clinics, Stanford

97239

VA Portland Health Care System, Portland

All Listed Sponsors
lead

Curium US LLC

INDUSTRY

NCT06235099 - Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer | Biotech Hunter | Biotech Hunter